| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/06/2008 | CN101119970A Azadecalin glucocorticoid receptor modulators |
| 02/06/2008 | CN101117335A Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
| 02/06/2008 | CN100366620C Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine) |
| 02/06/2008 | CN100366618C Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326788 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326784 Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy |
| 02/05/2008 | US7326719 Cathepsin S inhibitors |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326704 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests |
| 02/05/2008 | US7326699 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives |
| 02/05/2008 | CA2395204C Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials |
| 02/05/2008 | CA2205406C Novel benzyl pyrimidines |
| 01/31/2008 | WO2008014497A2 Aldh-2 inhibitors in the treatment of addiction |
| 01/31/2008 | WO2008014291A2 Compounds and compositions as hedgehog signaling pathway modulators |
| 01/31/2008 | WO2008014247A2 4 -arylalkoxymethyl-4- phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders |
| 01/31/2008 | WO2008013414A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 01/31/2008 | WO2008012623A1 Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 01/31/2008 | WO2008012227A2 Pyrazoles as glucokinase activators |
| 01/31/2008 | WO2008012027A1 Insecticidal compounds |
| 01/31/2008 | WO2007149395A3 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer |
| 01/31/2008 | WO2007120574A3 Diaryl substituted alkanes |
| 01/31/2008 | WO2007109459A3 Pyridines and pyridine n-oxides as modulators of thrombin |
| 01/31/2008 | WO2007075459A3 5-aryl isoxazolines for controlling invertebrate pests |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027219 Reacting 3-fluoro-4-morpholinyl aniline derivative with epichlorohydrin; converting chloromethyl oxazolidinone to aminomethyl oxazolidinone; carbonylation ; reacting with potassium phthalimide, hydrazine hydrate, and acetic anhydride; cyclization, carbamylation |
| 01/31/2008 | US20080027130 Cytotoxic agents comprising taxanes and their therapeutic use |
| 01/31/2008 | US20080027093 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/31/2008 | US20080027076 Pyrimidines With Tie2 (Tek) Activity |
| 01/31/2008 | US20080027071 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 01/31/2008 | US20080027059 Substituted isoxazolines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/31/2008 | US20080027058 Mitotic Kinesin Inhibitors |
| 01/31/2008 | US20080027056 Substituted heterocyclic ethers and their use in cns disorders |
| 01/31/2008 | US20080027055 1-Substituted indoles, and benzimidazoles additionally substituted with an amino ligand, e.g., 1-[(5-chlorothien-2-yl)sulfonyl]-5-[2-(piperidin-1-yl)ethoxy]-1H-indole; treating schizophrenia, depression, attention deficit disorder, Alzheimer's disease and Parkinson's disease |
| 01/31/2008 | US20080027054 4-Substituted quinolines as antitumor agents |
| 01/31/2008 | US20080027053 Antimicrobial oxazolidinone prodrugs |
| 01/31/2008 | US20080027051 Novel Heteroaryl Substituted Benzoxazoles |
| 01/31/2008 | US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio) |
| 01/31/2008 | US20080027048 2-Phenylthiophene Derivative |
| 01/31/2008 | US20080027047 Compounds that modulate HSP90 activity and methods for identifying same |
| 01/31/2008 | US20080027040 Oxazolidinone-Quinolone Hybrid Antibiotics |
| 01/31/2008 | US20080027037 Cyclic compounds |
| 01/31/2008 | US20080027035 Dpp-Iv Inhibitors |
| 01/31/2008 | US20080026135 Electron transport agents for organic electronic devices |
| 01/31/2008 | DE102006034916A1 Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten Coating of artificial surfaces of medical aids and appliances as well as cleaning and / or pretreatment of catheters and other medical tools and instruments |
| 01/31/2008 | CA2659192A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/31/2008 | CA2658925A1 Novel sulfonylamino acrylamide derivatives, isomer thereof,or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 01/31/2008 | CA2658901A1 Coating of artificial surfaces of medical aids and devices and cleaning and/or pretreatment of catheters and other medical aids and devices |
| 01/31/2008 | CA2658782A1 Compounds and compositions as hedgehog pathway modulators |
| 01/31/2008 | CA2657566A1 Pyrazoles as glucokinase activators |
| 01/31/2008 | CA2653056A1 Aldh-2 inhibitors in the treatment of addiction |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1881979A1 Novel oxadiazole derivatives and their medical use |
| 01/30/2008 | EP1881978A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives |
| 01/30/2008 | EP1881976A1 Substituted amide derivatives as protein kinase inhibitors |
| 01/30/2008 | EP1881975A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/30/2008 | EP1881967A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics |
| 01/30/2008 | EP1689350B1 Use of osteopontin in dental formulations |
| 01/30/2008 | CN101115742A Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 01/30/2008 | CN101115737A Novel salt form of a dopamine agonist |
| 01/30/2008 | CN101115734A Spiro derivatives as lipoxygenase inhibitors |
| 01/30/2008 | CN101115732A Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 01/30/2008 | CN101115731A Oxadiazole derivatives as DGAT inhibitors |
| 01/30/2008 | CN101115727A Compounds useful for inhibiting chk1 |
| 01/30/2008 | CN101115725A 2' and 3' - substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation |
| 01/30/2008 | CN101115718A N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid TRPV1 receptor ligands |
| 01/30/2008 | CN101115715A Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 01/30/2008 | CN101113137A Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/30/2008 | CN100364531C 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 01/29/2008 | US7323573 Production of polyketides |
| 01/29/2008 | US7323564 Preparation of thiazoles |
| 01/29/2008 | US7323464 Kinase inhibitors; autoimmune disease; antiinflammatory agents |
| 01/29/2008 | US7323462 Sexual disorders; anxiolytic agents; psychological disorders; analgesics; neurodegenerative disorders ; obsessive complusive disorders; antidepressants; headaches; schizophrenia; eating and sleep disorders |
| 01/29/2008 | US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 01/29/2008 | US7323456 Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient |
| 01/29/2008 | US7323455 1,2,3,5-Tetrahydro-4,1-benzoxazepine derivatives: 4-methyl-5-(5-methyl-2-oxo-5-phenyl-1,2,3,5-tetrahydro-4,1-benzoxazepin-7-yl)thiophene-2-carbonitrile; contraceptives; hormone replacement therapy |
| 01/29/2008 | CA2485433C Preparation of non-crystalline and crystalline dihydrate forms of azithromycin |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/24/2008 | WO2008011611A2 Compounds and compositions as itpkb inhibitors |
| 01/24/2008 | WO2008011190A1 Cgrp receptor antagonists |
| 01/24/2008 | WO2008011110A2 Di-amino-substituted heterocyclic compounds and methods of use |
| 01/24/2008 | WO2008010070A2 Novel oxazolidinone derivatives |
| 01/24/2008 | WO2008009750A2 Macrocyclic compounds useful as bace inhibitors |
| 01/24/2008 | WO2008009741A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 01/24/2008 | WO2008009487A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/24/2008 | WO2008009435A1 Amino-piperidine derivatives as cetp inhibitors |
| 01/24/2008 | WO2008009406A1 Novel pyridazine derivatives |
| 01/24/2008 | WO2008009078A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| 01/24/2008 | WO2007137417B1 Heterocyclic compounds as calcium channel blockers |
| 01/24/2008 | WO2007137196A3 Tubulin binding anti cancer compounds and prodrugs thereof |
| 01/24/2008 | WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 01/24/2008 | WO2007130823A3 Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor |
| 01/24/2008 | WO2007128086A3 Novel viral replication inhibitor |
| 01/24/2008 | WO2007126957A3 New compounds |
| 01/24/2008 | WO2007096261A3 Process for the preparation of dioxane derivatives |